Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a video on X:
“Teclistamab and Daratumumab in relapsed myeloma!”
Watch the video
More posts featuring Al-Ola A Abdallah